References
Abdelhamid, M., Jung, C.G., Zhou, C., Abdullah, M., Nakano, M.,
Wakabayashi, H., Abe, F., and Michikawa, M. (2020). Dietary Lactoferrin
Supplementation Prevents Memory Impairment and Reduces Amyloid-beta
Generation in J20 Mice. J Alzheimers Dis , 74 , 245-259.
Castro-Alvarez, J.F., Uribe-Arias, S.A., Mejia-Raigosa, D., and
Cardona-Gomez, G.P. (2014). Cyclin-dependent kinase 5, a node protein in
diminished tauopathy: a systems biology approach. Front Aging
Neurosci , 6 , 232.
Chiou, J.T., Huang, C.H., Wu, T.H., Wang, L.J., Lee, Y.C., Huang, P.W.,
and Chang, L.S. (2022). CREB/Sp1-mediated MCL1 expression and
NFkappaB-mediated ABCB1 expression modulate the cytotoxicity of
daunorubicin in chronic myeloid leukemia cells. Toxicol Appl
Pharmacol , 435 , 115847.
Deyts, C., Thinakaran, G., and Parent, A.T. (2016). APP Receptor? To Be
or Not To Be. Trends Pharmacol Sci , 37 , 390-411.
Fan, Y.G., Guo, T., Han, X.R., Liu, J.L., Cai, Y.T., Xue, H., Huang,
X.S., Li, Y.C., Wang, Z.Y., and Guo, C. (2019). Paricalcitol accelerates
BACE1 lysosomal degradation and inhibits calpain-1 dependent neuronal
loss in APP/PS1 transgenic mice. EBioMedicine , 45 ,
393-407.
Frohner, I.E., Mudrak, I., Schuchner, S., Anrather, D., Hartl, M.,
Sontag, J.M., Sontag, E., Wadzinski, B.E., Preglej, T., Ellmeier,
W., et al. (2020). PP2AC Phospho-Tyr(307) Antibodies Are Not
Specific for this Modification but Are Sensitive to Other PP2AC
Modifications Including Leu(309) Methylation. Cell Rep ,30 , 3171-3182 e3176.
Gleerup, H.S., Jensen, C.S., Hogh, P., Hasselbalch, S.G., and Simonsen,
A.H. (2021). Lactoferrin in cerebrospinal fluid and saliva is not a
diagnostic biomarker for Alzheimer’s disease in a mixed memory clinic
population. EBioMedicine , 67 , 103361.
Gonzalez-Sanchez, M., Bartolome, F., Antequera, D., Puertas-Martin, V.,
Gonzalez, P., Gomez-Grande, A., Llamas-Velasco, S., Herrero-San Martin,
A., Perez-Martinez, D., Villarejo-Galende, A., et al. (2020).
Decreased salivary lactoferrin levels are specific to Alzheimer’s
disease. EBioMedicine , 57 , 102834.
Grethe, S., and Porn-Ares, M.I. (2006). p38 MAPK regulates
phosphorylation of Bad via PP2A-dependent suppression of the
MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial
apoptosis. Cell Signal , 18 , 531-540.
Guillonneau, M., Paris, F., Dutoit, S., Estephan, H., Beneteau, E.,
Huot, J., and Corre, I. (2016). Oxidative stress disassembles the
p38/NPM/PP2A complex, which leads to modulation of
nucleophosmin-mediated signaling to DNA damage response. FASEB J ,30 , 2899-2914.
Guo, C., Yang, Z.H., Zhang, S., Chai, R., Xue, H., Zhang, Y.H., Li,
J.Y., and Wang, Z.Y. (2017). Intranasal Lactoferrin Enhances
alpha-Secretase-Dependent Amyloid Precursor Protein Processing via the
ERK1/2-CREB and HIF-1alpha Pathways in an Alzheimer’s Disease Mouse
Model. Neuropsychopharmacology , 42 , 2504-2515.
Hsiao, P.C., Chang, J.H., Lee, W.J., Ku, C.C., Tsai, M.Y., Yang, S.F.,
and Chien, M.H. (2020). The Curcumin Analogue, EF-24, Triggers p38
MAPK-Mediated Apoptotic Cell Death via Inducing PP2A-Modulated ERK
Deactivation in Human Acute Myeloid Leukemia Cells. Cancers
(Basel) , 12 .
Hu, W., Wang, Z., Zhang, H., Mahaman, Y.A.R., Huang, F., Meng, D., Zhou,
Y., Wang, S., Jiang, N., Xiong, J., et al. (2022). Chk1
Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive
Dysfunction Through CIP2A/PP2A Signaling. Neurotherapeutics .
Iannuzzi, F., Sirabella, R., Canu, N., Maier, T.J., Annunziato, L., and
Matrone, C. (2020). Fyn Tyrosine Kinase Elicits Amyloid Precursor
Protein Tyr682 Phosphorylation in Neurons from Alzheimer’s Disease
Patients. Cells , 9 .
Kanekiyo, T., Cirrito, J.R., Liu, C.C., Shinohara, M., Li, J., Schuler,
D.R., Shinohara, M., Holtzman, D.M., and Bu, G. (2013). Neuronal
clearance of amyloid-beta by endocytic receptor LRP1. J Neurosci ,33 , 19276-19283.
Kawamata, T., Tooyama, I., Yamada, T., Walker, D.G., and McGeer, P.L.
(1993). Lactotransferrin immunocytochemistry in Alzheimer and normal
human brain. Am J Pathol , 142 , 1574-1585.
Keeney, J.T., Swomley, A.M., Harris, J.L., Fiorini, A., Mitov, M.I.,
Perluigi, M., Sultana, R., and Butterfield, D.A. (2012). Cell cycle
proteins in brain in mild cognitive impairment: insights into
progression to Alzheimer disease. Neurotox Res , 22 ,
220-230.
Lee, M.S., Kao, S.C., Lemere, C.A., Xia, W., Tseng, H.C., Zhou, Y.,
Neve, R., Ahlijanian, M.K., and Tsai, L.H. (2003). APP processing is
regulated by cytoplasmic phosphorylation. J Cell Biol ,163 , 83-95.
Lee, S.H., Kang, J., Ho, A., Watanabe, H., Bolshakov, V.Y., and Shen, J.
(2020). APP Family Regulates Neuronal Excitability and Synaptic
Plasticity but Not Neuronal Survival. Neuron , 108 , 676-690
e678.
Leveugle, B., Spik, G., Perl, D.P., Bouras, C., Fillit, H.M., and Hof,
P.R. (1994). The iron-binding protein lactotransferrin is present in
pathologic lesions in a variety of neurodegenerative disorders: a
comparative immunohistochemical analysis. Brain Res , 650 ,
20-31.
Liu, L., Lauro, B.M., Ding, L., Rovere, M., Wolfe, M.S., and Selkoe,
D.J. (2019). Multiple BACE1 inhibitors abnormally increase the BACE1
protein level in neurons by prolonging its half-life. Alzheimers
Dement , 15 , 1183-1194.
Liu, M., Fan, F., Shi, P., Tu, M., Yu, C., Yu, C., and Du, M. (2018).
Lactoferrin promotes MC3T3-E1 osteoblast cells proliferation via MAPK
signaling pathways. Int J Biol Macromol , 107 , 137-143.
Lu, L., Zheng, X., Wang, S., Tang, C., Zhang, Y., Yao, G., Zeng, J., Ge,
S., Wen, H., Xu, M., et al. (2020). Anti-Abeta agents for mild to
moderate Alzheimer’s disease: systematic review and meta-analysis.J Neurol Neurosurg Psychiatry , 91 , 1316-1324.
Ma, K.G., Lv, J., Hu, X.D., Shi, L.L., Chang, K.W., Chen, X.L., Qian,
Y.H., Yang, W.N., and Qu, Q.M. (2016). The p38 mitogen-activated protein
kinase signaling pathway is involved in regulating low-density
lipoprotein receptor-related protein 1-mediated beta-amyloid protein
internalization in mouse brain. Int J Biochem Cell Biol ,76 , 75-86.
Mazhar, S., Leonard, D., Sosa, A., Schlatzer, D., Thomas, D., and Narla,
G. (2020). Challenges and Reinterpretation of Antibody-Based Research on
Phosphorylation of Tyr(307) on PP2Ac. Cell Rep , 30 ,
3164-3170 e3163.
Menon, P.K., Koistinen, N.A., Iverfeldt, K., and Strom, A.L. (2019).
Phosphorylation of the amyloid precursor protein (APP) at Ser-675
promotes APP processing involving meprin beta. J Biol Chem ,294 , 17768-17776.
Mohamed, W.A., Salama, R.M., and Schaalan, M.F. (2019). A pilot study on
the effect of lactoferrin on Alzheimer’s disease pathological sequelae:
Impact of the p-Akt/PTEN pathway. Biomed Pharmacother ,111 , 714-723.
Shentu, Y.P., Huo, Y., Feng, X.L., Gilbert, J., Zhang, Q., Liuyang,
Z.Y., Wang, X.L., Wang, G., Zhou, H., Wang, X.C., et al. (2018).
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits
in Alzheimer’s Disease. Cell Rep , 24 , 713-723.
Sisodia, S.S. (1992). Beta-amyloid precursor protein cleavage by a
membrane-bound protease. Proc Natl Acad Sci U S A , 89 ,
6075-6079.
Son, S.M., Cha, M.Y., Choi, H., Kang, S., Choi, H., Lee, M.S., Park,
S.A., and Mook-Jung, I. (2016). Insulin-degrading enzyme secretion from
astrocytes is mediated by an autophagy-based unconventional secretory
pathway in Alzheimer disease. Autophagy , 12 , 784-800.
Sontag, J.M., and Sontag, E. (2014). Protein phosphatase 2A dysfunction
in Alzheimer’s disease. Front Mol Neurosci , 7 , 16.
Storck, S.E., Meister, S., Nahrath, J., Meissner, J.N., Schubert, N., Di
Spiezio, A., Baches, S., Vandenbroucke, R.E., Bouter, Y., Prikulis,
I., et al. (2016). Endothelial LRP1 transports amyloid-beta(1-42)
across the blood-brain barrier. J Clin Invest , 126 ,
123-136.
Tang, L., Wu, J.J., Ma, Q., Cui, T., Andreopoulos, F.M., Gil, J.,
Valdes, J., Davis, S.C., and Li, J. (2010). Human lactoferrin stimulates
skin keratinocyte function and wound re-epithelialization. Br J
Dermatol , 163 , 38-47.
Tsatsanis, A., McCorkindale, A.N., Wong, B.X., Patrick, E., Ryan, T.M.,
Evans, R.W., Bush, A.I., Sutherland, G.T., Sivaprasadarao, A.,
Guennewig, B., et al. (2021). The acute phase protein lactoferrin
is a key feature of Alzheimer’s disease and predictor of Abeta burden
through induction of APP amyloidogenic processing. Mol
Psychiatry , 26 , 5516-5531.
Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A.,
Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., et
al. (1999). Beta-secretase cleavage of Alzheimer’s amyloid precursor
protein by the transmembrane aspartic protease BACE. Science ,286 , 735-741.
Wang, Y., Xia, Y., Kuang, D., Duan, Y., and Wang, G. (2017). PP2A
regulates SCF-induced cardiac stem cell migration through interaction
with p38 MAPK. Life Sci , 191 , 59-67.
Weyer, S.W., Klevanski, M., Delekate, A., Voikar, V., Aydin, D., Hick,
M., Filippov, M., Drost, N., Schaller, K.L., Saar, M., et al.(2011). APP and APLP2 are essential at PNS and CNS synapses for
transmission, spatial learning and LTP. EMBO J , 30 ,
2266-2280.
Xia, Y., Prokop, S., and Giasson, B.I. (2021). ”Don’t Phos Over Tau”:
recent developments in clinical biomarkers and therapies targeting tau
phosphorylation in Alzheimer’s disease and other tauopathies. Mol
Neurodegener , 16 , 37.
Xu, S.F., Pang, Z.Q., Fan, Y.G., Zhang, Y.H., Meng, Y.H., Bai, C.Y.,
Jia, M.Y., Chen, Y.H., Wang, Z.Y., and Guo, C. (2022).
Astrocyte-specific loss of lactoferrin influences neuronal structure and
function by interfering with cholesterol synthesis. Glia .
Yang, W.N., Ma, K.G., Qian, Y.H., Zhang, J.S., Feng, G.F., Shi, L.L.,
Zhang, Z.C., and Liu, Z.H. (2015). Mitogen-activated protein kinase
signaling pathways promote low-density lipoprotein receptor-related
protein 1-mediated internalization of beta-amyloid protein in primary
cortical neurons. Int J Biochem Cell Biol , 64 , 252-264.
Zhang, W., Guo, H., Jing, H., Li, Y., Wang, X., Zhang, H., Jiang, L.,
and Ren, F. (2014). Lactoferrin stimulates osteoblast differentiation
through PKA and p38 pathways independent of lactoferrin’s receptor LRP1.J Bone Miner Res , 29 , 1232-1243.